Biostratum Incorporated Durham, NC - 27713

Biostratum Incorporated is categorized under Commercial Medical Research in Durham, NC and active since 1994.

Biostratum Incorporated was established in 1994, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Robert J Schotzinger at the company’s single location by writing to 2300 Englert Drive # G, Durham, North Carolina NC 27713 or by phoning (919) 433-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Biostratum Incorporated
Contact Person: Robert J Schotzinger
Address: 2300 Englert Drive # G, Durham, North Carolina 27713
Phone Number: (919) 433-1000
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1994
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Biostratum Incorporated was started in 1994 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Robert J Schotzinger for inquiries that concern Biostratum Incorporated by calling the company number (919) 433-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Biostratum Incorporated can be found at the coordinates 35.895178,-78.890681 as well as the street address 2300 Englert Drive # G in Durham, North Carolina 27713.

For its online presence, you may visit Biostratum Incorporated’s website at and engage with its social media outlets through on Twitter and on Facebook.